MannKind Is 'Making Progress' On Its Alternative To Mylan's EpiPen, Report Says
August 30, 2016 at 15:50 PM EDT
Biopharmaceutical company MannKind Corporation (NASDAQ: MNKD) is "making progress" in developing a less costly alternative to Mylan NV ...